SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-315711
Filing Date
2019-12-17
Accepted
2019-12-17 09:12:40
Documents
13
Period of Report
2019-12-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d851417d8k.htm   iXBRL 8-K 31406
2 EX-3.1 d851417dex31.htm EX-3.1 152591
  Complete submission text file 0001193125-19-315711.txt   352517

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA nktr-20191212.xsd EX-101.SCH 3095
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE nktr-20191212_lab.xml EX-101.LAB 18126
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nktr-20191212_pre.xml EX-101.PRE 11422
13 EXTRACTED XBRL INSTANCE DOCUMENT d851417d8k_htm.xml XML 3443
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 191288684
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences